Objectives: We performed a comparative study of laparoscopic radical nephrectomy (LRN) and open radical nephrectomy (ORN) for renal cell carcinoma, and a comparative study of transperitoneal (LRN-TP) versus retroperitoneal LRN (LRN-RP) for renal cell carcinoma. Materials and Methods: A total of 100 patients underwent radical nephrectomy for stage T1 and T2 disease. Of the 100 cases, 34 (34.0%) were treated with LRN-TP, 33 (33.0%) with LRN-RP, and 33 (33.0%) with ORN. Each group was reviewed with respect to complications, postoperative convalescence, and the relationship between body mass index and operative time. Results: Mean operative times of LRN-TP, LRN-RP and ORN were 305.7, 296.2, and 218.1 min, and mean blood losses were 236.3, 101.7, and 690.5 ml, respectively. Body mass index and mean operative time exhibited equilateral correlation in the three groups. In one case (1.5%) of LRN (67 cases), conversion to open surgery was necessary due to bleeding, and LRN-TP was performed. In one case (1.5%), intraoperative complications occurred but could be managed laparoscopically. Three cases (9.1%) of ORN required blood transfusion. Conclusions: LRN results in less blood loss, less postoperative pain, quicker oral intake, shorter hospitalization, and a more rapid recovery than ORN, although LRN requires longer operative time than ORN.

Keywords:
Renal cell carcinoma, Laparoscopic radical nephrectomy, Open radical nephrectomy
This content is only available via PDF.
© 2008 S. Karger AG, Basel
2008
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.